Cholinergic markers in aged cognitively impaired Long-Evans rats
Aged Long-Evans rats (24–25 months old) were classified into cognitively impaired or
unimpaired subgroups based on their performances in the Morris Swim Maze task …
unimpaired subgroups based on their performances in the Morris Swim Maze task …
(+)-[18F]Flubatine as a novel α4β2 nicotinic acetylcholine receptor PET ligand—results of the first-in-human brain imaging application in patients with β-amyloid PET …
Purposes We present the first in-human brain PET imaging data of the new α4β2 nicotinic
acetylcholine receptor (nAChR)–targeting radioligand (+)-[18 F] Flubatine. Aims were to …
acetylcholine receptor (nAChR)–targeting radioligand (+)-[18 F] Flubatine. Aims were to …
The inhibitory and facilitatory actions of amyloid-β peptides on nicotinic ACh receptors and AMPA receptors
H Tozaki, A Matsumoto, T Kanno, K Nagai… - Biochemical and …, 2002 - Elsevier
The present study investigated the effects of amyloid-β peptides on nicotinic ACh receptors
(Torpedo, α4β2, and α7 receptors) and AMPA receptors expressed in Xenopus oocytes by …
(Torpedo, α4β2, and α7 receptors) and AMPA receptors expressed in Xenopus oocytes by …
Cognitive impairment in spontaneously hypertensive rats: role of central nicotinic receptors. Part II
M Gattu, AV Terry Jr, JR Pauly, JJ Buccafusco - Brain research, 1997 - Elsevier
The adult spontaneously hypertensive rat (SHR) has been shown to exhibit a decrease in
the expression and nicotine-stimulated function of brain nicotinic acetylcholine receptors …
the expression and nicotine-stimulated function of brain nicotinic acetylcholine receptors …
Differential effects of scopolamine and mecamylamine on working and reference memory in the rat
PM Moran - Pharmacology Biochemistry and Behavior, 1993 - Elsevier
The effects of the muscarinic antagonist scopolamine (0.1–0.6 mg/kg, IP) and the nicotinic
antagonist mecamylamine (1–10 mg/kg) were compared in T-maze alternation and …
antagonist mecamylamine (1–10 mg/kg) were compared in T-maze alternation and …
Copper reduces Aβ oligomeric species and ameliorates neuromuscular synaptic defects in a C. elegans model of inclusion body myositis
DL Rebolledo, R Aldunate, R Kohn, I Neira… - Journal of …, 2011 - Soc Neuroscience
Alzheimer's disease and inclusion body myositis (IBM) are disorders frequently found in the
elderly and characterized by the presence of amyloid-β peptide (Aβ) aggregates. We used C …
elderly and characterized by the presence of amyloid-β peptide (Aβ) aggregates. We used C …
Perception is far from perfection: the role of the brain and mind in constructing realities
IE Dror - Behavioral and Brain Sciences, 2005 - cambridge.org
Dichotomizing perceptions, by those that have an objective reality and those that do not, is
rejected. Perceptions are suggested to fall along a multidimensional continuum in which …
rejected. Perceptions are suggested to fall along a multidimensional continuum in which …
The role of nicotine and nicotinic mechanisms in neuropsychiatric disease
PA Newhouse, JR Hughes - British journal of addiction, 1991 - Wiley Online Library
Cigarette smoking, and by implication nicotine, may be involved as a negative or positive
risk factor in some neuropsychiatric disorders and possibly as a treatment in others. Nicotine …
risk factor in some neuropsychiatric disorders and possibly as a treatment in others. Nicotine …
Minor alkaloids of tobacco release [3H] dopamine from superfused rat striatal slices
LP Dwoskin, LH Teng, ST Buxton, A Ravard… - European journal of …, 1995 - Elsevier
In addition to S (−)-nicotine, several minor tobacco alkaloids ((±)-nornicotine, anabaseine, S
(−)-anabasine, and S (−)-N-methylanabasine) are present in tobacco smoke. This study …
(−)-anabasine, and S (−)-N-methylanabasine) are present in tobacco smoke. This study …
Targeting the cholinergic system to develop a novel therapy for Huntington's disease
GX D'Souza, HJ Waldvogel - Journal of Huntington's Disease, 2016 - content.iospress.com
In this review, we outline the role of the cholinergic system in Huntington's disease, and
briefly describe the dysfunction of cholinergic transmission, cholinergic neurons, cholinergic …
briefly describe the dysfunction of cholinergic transmission, cholinergic neurons, cholinergic …